NCT06655727

Brief Summary

The primary aim of this study is to perform an ultrasonographic swallowing assessment in Parkinson's patients and healthy volunteers and compare the findings with those from clinical swallowing evaluations. The secondary aim is to examine the relationship between dysphagia and functional status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 23, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

October 25, 2024

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

21 days

First QC Date

October 22, 2024

Last Update Submit

January 26, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • The EAT-10 (Eating Assessment Tool-10)

    The EAT-10 (Eating Assessment Tool-10) is a validated self-administered questionnaire designed to assess symptoms of dysphagia (difficulty swallowing). It consists of 10 questions that evaluate the severity of swallowing difficulties, including issues related to eating, drinking, and managing saliva. Each item is rated on a 5-point scale, ranging from 0 (no problem) to 4 (severe problem). A total score of 3 or higher suggests the presence of clinically significant dysphagia, and it helps guide further diagnostic evaluation and management.

    0 day

  • Unified Parkinson's Disease Rating Scale (UPDRS)

    The UPDRS is a comprehensive tool used to evaluate the severity and progression of Parkinson's disease. It consists of multiple sections assessing motor and non-motor symptoms, helping clinicians understand the impact of the disease on daily functioning. The UPDRS is widely used in both clinical practice and research to monitor disease progression and treatment effects. In the MDS-UPDRS, higher scores indicate more severe Parkinson's disease symptoms. Each item is rated from 0 (normal) to 4 (severe), with the total score reflecting the overall disease severity. A higher total score means worse motor and non-motor symptoms, indicating greater impairment and reduced quality of life. Lower scores suggest milder symptoms and better functional status.

    0 day

Secondary Outcomes (3)

  • Tongue Thickness

    0 day

  • Distance Between the Hyoid and Mandible

    0 day

  • Hyoid Displacement Distance:

    0 day

Study Arms (2)

Parkinson disease group

Patients with Parkinson's disease

Diagnostic Test: Ultrasound evaluation

Control group

Healthy volunteers

Diagnostic Test: Ultrasound evaluation

Interventions

Ultrasound evaluationDIAGNOSTIC_TEST

No intervention

Control groupParkinson disease group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Parkinson's Disease and healthy controls

You may qualify if:

  • Diagnosis of idiopathic Parkinson's disease by a neurologist.
  • Being in stages 1-3 according to the Modified Hoehn-Yahr Staging Scale.
  • Scoring at least 24 on the Mini-Mental State Examination (MMSE).
  • Not having received any therapy or treatment affecting swallowing, other than routine medication for Parkinson's disease.

You may not qualify if:

  • Presence of head or neck cancer that could cause dysphagia.
  • History of radiotherapy or surgery in the head and neck region.
  • Diagnosis of vascular parkinsonism or stroke.
  • Presence of cardiopulmonary disease that could affect swallowing or breathing.
  • Having received voice or swallowing therapy in the last 6 months.
  • Presence of a diagnosed psychiatric disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beylikdüzü State Hospital

Istanbul, 34147, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

October 22, 2024

First Posted

October 23, 2024

Study Start

October 25, 2024

Primary Completion

November 15, 2024

Study Completion

November 15, 2024

Last Updated

January 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations